Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 496 of 6351
-
Four brain chips could let paralyzed people control computers with thought alone
Disease control Recruiting nowThis research study is being done to develop a novel brain-computer interface (BCI) technology that can enable severely paralyzed individuals to interact with the world through direct brain-control of a computer. This technology is named MindEx (for Mind Extender). It utilizes fo…
Sponsor: Nader Pouratian • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Universal CAR-T cells take on lupus and more in early trial
Disease control Recruiting nowA single arm, open-label pilot study is designed to determine the safety and effectiveness of anti-CD19/BCMA U CAR T cells in patients with autoimmune diseases. 60 patients are planned to be enrolled in the dose-escalation trial.
Early phase 1 • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could a simple exercise class help us age better?
Prevention By invitation onlyIntroduction: Extension projects focused on physical activity can offer health practices and promote quality of life for participants of different ages. Investing in extension projects with a research interface can contribute to relevant insights for teaching knowledge. Furthermo…
Phase 1 • Sponsor: Federal University of the Valleys of Jequitinhonha and Mucuri • Aim: Prevention
Last updated Aug 19, 2026 00:00 UTC
-
New eye injection could restore sight in corneal swelling patients
Disease control Recruiting nowThe purpose of this study is to assess the efficacy and safety of single injection dose of AURN001 compared with placebo in adult participants with corneal edema secondary to corneal endothelial dysfunction.
Phase 3 • Sponsor: Aurion Biotech • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for hard-to-treat lung cancer: drug combo targets resistant tumors
Disease control Recruiting nowThis phase II trial tests how well telisotuzumab vedotin and osimertinib works for the treatment of non small cell lung cancer that is growing, spreading, or getting worse (progressive) and for which no treatment is currently available (incurable). Telisotuzumab vedotin is a mono…
Phase 2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Spinal stimulation plus step training shows promise for walking recovery
Disease control Recruiting nowA well-established rehabilitation strategy for improvements of standing and walking ability in persons with spinal cord injury (SCI) is step training on a motorized treadmill with body weight support. A promising intervention is stimulation of the spinal cord through the skin (tr…
Sponsor: Maria Knikou, PT, MBA, PhD • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Can cash rewards and a breathalyzer app help people stay sober?
Disease control Recruiting nowAlcohol Use Disorder (AUD) is a major public health concern associated with substantial morbidity, mortality, and impaired social and occupational functioning. Contingency Management (CM) is an evidence-based behavioral intervention that provides incentives contingent on abstinen…
Sponsor: University of Sao Paulo General Hospital • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Which drug restores blood pressure faster in children with septic shock?
Disease control OngoingThis randomized clinical trial was conducted to compare dopamine with epinephrine as the first vasoactive treatment in children aged 2 to 12 years with fluid-refractory hypotensive septic shock. Children who remained hypotensive with signs of poor tissue perfusion after receiving…
Sponsor: Nishtar Medical University • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Can early rhythm control save hearts in AF patients with leaky valves?
Disease control Recruiting nowAtrial fibrillation is frequently accompanied by tricuspid regurgitation and may contribute to right atrial and tricuspid annular remodeling, leading to progression of tricuspid regurgitation and adverse clinical outcomes. However, whether early rhythm control improves prognosis …
Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for Hard-to-Treat myeloma: experimental combo enters phase 2
Disease control Recruiting nowThis is a Phase 2, open-label, single-arm, multicenter study to assess the antimyeloma activity and further characterize the safety, tolerability, PK, and PD of cemsidomide in combination with dexamethasone in participants with relapsed/refractory multiple myeloma (r/r MM).
Phase 2 • Sponsor: C4 Therapeutics, Inc. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New shot could train body to tolerate peanuts
Disease control Recruiting nowThis study will test a new investigational treatment called UKK-0018. UKK-0018 as an immunotherapeutic for the treatment of peanut allergies. The treatment is given by injection and is designed to train the immune system to tolerate peanut exposure over time.
Phase 1/2 • Sponsor: Ukko Inc • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Smartwatch and app join fight against metastatic breast cancer
Disease control Recruiting nowThis is an open-label, single arm, non-randomized, multicenter, phase 2 study assessing the efficacy and safety of T-DXd as first-line treatment in HER2-positive advanced/metastatic BC patients (N=300). The study integrates digital health tools for proactive toxicity management a…
Phase 2 • Sponsor: SOLTI Breast Cancer Research Group • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New combo aims to shrink hard-to-treat breast tumors
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of inavolisib in combination with fulvestrant compared with inavolisib in combination with fulvestrant in participants with PIK3CA-mutated, HR-positive, HER2-negative locally advanced or metastatic breast cancer (LA…
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Experimental CAR-T therapy targets tough lymphoma in early trial
Disease control Recruiting nowThe goal of this clinical research study is to find the highest tolerable dose of JV-394 (a type of autologous CAR-T cell therapy) that can be given to patients who have T/NK cell lymphoma that is relapsed or refractory. The safety and possible side effects of JV-394 will also be…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Could a common arthritis drug tame a rare, fatal blood vessel disease?
Disease control Recruiting nowBackground: Kohlmeier-Degos (KD) is a rare disease that causes inflammation and blood clots, leading to blockages in small blood vessels. These blockages can result in K-D lesions throughout the body, affecting the skin, lungs, heart, spinal cord, and brain. KD can be fatal. No …
Phase 2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Which DBS setting works best for Parkinson's? a trial puts anodic vs cathodic to the test
Disease control OngoingRandomized, double-blind, crossover design, interventional study to assess the differences between mixed cathodic/anodic, pure cathodic, and pure anodic stimulation with respect to efficacy, side effect thresholds, symptom control, and quality of life in Parkinson's Disease patie…
Sponsor: University of South Florida • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can an herbal formula boost lung cancer treatment?
Disease control By invitation onlyGlobally, lung cancer stands as the foremost cause of cancer-related mortality. Among its subtypes, small cell lung cancer (SCLC) represents an exceptionally aggressive malignancy, accounting for approximately 15-20% of all lung cancer cases. Over two-thirds of SCLC patients are …
Sponsor: LI FENG • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New eye implant could replace daily glaucoma drops
Disease control Recruiting nowEvaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Phase 3 • Sponsor: Glaukos Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
A new care pathway aims to get cancer surgery patients home safer and faster
Disease control Recruiting nowThe goal of this randomized controlled clinical trial is to evaluate whether the Ready for Safe Cancer Treatment (RESET) program improves perioperative care and supports safe hospital discharge in two surgical populations: adult patients undergoing planned oncological surgery and…
Sponsor: Regional Specialist Hospital in Wroclaw • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New eye drug could cut injection frequency for Diabetes-Related vision loss
Disease control OngoingThis is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.
Phase 3 • Sponsor: EyePoint Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC